companies that make glp-1 drugs Swiss Re says could reduce US mortality by up to 6.4% Personalized GLP-1/GIP+B12 - Kin Meds

113 Patients with active UC and CD had higher amounts of bioactive GLP-2 than healthy controls, according to a study by Xiao et al

Of note, more than 50% of participants in the tirzepatide 10 and 15 mg groups experienced weight reductions of over 20%

Journal of Managed Care & Specialty Pharmacy

Keep in mind that some of these contain caffeine or other stimulants, so youll want to make sure that you dont overdo it on top of the caffeine you may already be having in your day

This study explores real-world outcomes of oral semaglutide (GLP-1 receptor agonist) in Indian patients with Type 2 Diabetes Mellitusan area where data remain limited in India

The Lancet Psychiatry [Internet]